Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Biochem Pharmacol
2021 Jan 01;183:114291. doi: 10.1016/j.bcp.2020.114291.
Show Gene links
Show Anatomy links
Small cyclic sodium channel inhibitors.
Peigneur S
,
da Costa Oliveira C
,
de Sousa Fonseca FC
,
McMahon KL
,
Mueller A
,
Cheneval O
,
Cristina Nogueira Freitas A
,
Starobova H
,
Dimitri Gama Duarte I
,
Craik DJ
,
Vetter I
,
de Lima ME
,
Schroeder CI
,
Tytgat J
.
???displayArticle.abstract???
Voltage-gated sodium (NaV) channels play crucial roles in a range of (patho)physiological processes. Much interest has arisen within the pharmaceutical industry to pursue these channels as analgesic targets following overwhelming evidence that NaV channel subtypes NaV1.7-NaV1.9 are involved in nociception. More recently, NaV1.1, NaV1.3 and NaV1.6 have also been identified to be involved in pain pathways. Venom-derived disulfide-rich peptide toxins, isolated from spiders and cone snails, have been used extensively as probes to investigate these channels and have attracted much interest as drug leads. However, few peptide-based leads have made it as drugs due to unfavourable physiochemical attributes including poor in vivo pharmacokinetics and limited oral bioavailability. The present work aims to bridge the gap in the development pipeline between drug leads and drug candidates by downsizing these larger venom-derived NaV inhibitors into smaller, more "drug-like" molecules. Here, we use molecular engineering of small cyclic peptides to aid in the determination of what drives subtype selectivity and molecular interactions of these downsized inhibitors across NaV subtypes. We designed a series of small, stable and novel NaV probes displaying NaV subtype selectivity and potency in vitro coupled with potent in vivo analgesic activity, involving yet to be elucidated analgesic pathways in addition to NaV subtype modulation.
Aley,
Role of protein kinase A in the maintenance of inflammatory pain.
1999, Pubmed
Aley,
Role of protein kinase A in the maintenance of inflammatory pain.
1999,
Pubmed
Bhardwaj,
Accurate de novo design of hyperstable constrained peptides.
2016,
Pubmed
Binshtok,
Nociceptors are interleukin-1beta sensors.
2008,
Pubmed
Black,
Changes in the expression of tetrodotoxin-sensitive sodium channels within dorsal root ganglia neurons in inflammatory pain.
2004,
Pubmed
Bulaj,
Novel conotoxins from Conus striatus and Conus kinoshitai selectively block TTX-resistant sodium channels.
2005,
Pubmed
Cardoso,
Sodium channels and pain: from toxins to therapies.
2018,
Pubmed
Cestèle,
Molecular mechanisms of neurotoxin action on voltage-gated sodium channels.
2000,
Pubmed
Craik,
The future of peptide-based drugs.
2013,
Pubmed
Cummins,
Sodium channels and the molecular pathophysiology of pain.
2000,
Pubmed
Deuis,
Analgesic Effects of GpTx-1, PF-04856264 and CNV1014802 in a Mouse Model of NaV1.7-Mediated Pain.
2016,
Pubmed
Dib-Hajj,
Voltage-gated sodium channels in pain states: role in pathophysiology and targets for treatment.
2009,
Pubmed
Diniz,
The purification and amino acid sequence of the lethal neurotoxin Tx1 from the venom of the Brazilian 'armed' spider Phoneutria nigriventer.
1990,
Pubmed
Durek,
Chemical engineering and structural and pharmacological characterization of the α-scorpion toxin OD1.
2013,
Pubmed
Fitzgerald,
cAMP-dependent phosphorylation of the tetrodotoxin-resistant voltage-dependent sodium channel SNS.
1999,
Pubmed
French,
The tetrodotoxin receptor of voltage-gated sodium channels--perspectives from interactions with micro-conotoxins.
2010,
Pubmed
Gold,
Modulation of TTX-R INa by PKC and PKA and their role in PGE2-induced sensitization of rat sensory neurons in vitro.
1998,
Pubmed
Green,
Venom Peptides From Cone Snails: Pharmacological Probes for Voltage-Gated Sodium Channels.
2016,
Pubmed
Green,
Structure and function of μ-conotoxins, peptide-based sodium channel blockers with analgesic activity.
2014,
Pubmed
Griswold,
Endothelin B receptor modulates inflammatory pain and cutaneous inflammation.
1999,
Pubmed
Hermanns,
Molecular mechanisms of action of systemic lidocaine in acute and chronic pain: a narrative review.
2019,
Pubmed
Israel,
Sodium Channels and Venom Peptide Pharmacology.
2017,
Pubmed
Kawabata,
L-leucyl-L-arginine, naltrindole and D-arginine block antinociception elicited by L-arginine in mice with carrageenin-induced hyperalgesia.
1992,
Pubmed
Khasar,
A tetrodotoxin-resistant sodium current mediates inflammatory pain in the rat.
1998,
Pubmed
Kilkenny,
Animal research: reporting in vivo experiments: the ARRIVE guidelines.
2010,
Pubmed
Lewis,
Conus venom peptide pharmacology.
2012,
Pubmed
Lipkind,
KcsA crystal structure as framework for a molecular model of the Na(+) channel pore.
2000,
Pubmed
Liu,
Prostaglandin E2 promotes Na1.8 trafficking via its intracellular RRR motif through the protein kinase A pathway.
2010,
Pubmed
Markgraf,
Mechanism and molecular basis for the sodium channel subtype specificity of µ-conopeptide CnIIIC.
2012,
Pubmed
Martin-Moutot,
Phoneutria nigriventer toxin 1: a novel, state-dependent inhibitor of neuronal sodium channels that interacts with micro conotoxin binding sites.
2006,
Pubmed
McArthur,
Interactions of key charged residues contributing to selective block of neuronal sodium channels by μ-conotoxin KIIIA.
2011,
Pubmed
McGrath,
Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP.
2015,
Pubmed
McMahon,
Discovery, Pharmacological Characterisation and NMR Structure of the Novel µ-Conotoxin SxIIIC, a Potent and Irreversible NaV Channel Inhibitor.
2020,
Pubmed
Melnikova,
Addressing the Issue of Tetrodotoxin Targeting.
2018,
Pubmed
Murray,
Single Residue Substitutions That Confer Voltage-Gated Sodium Ion Channel Subtype Selectivity in the NaV1.7 Inhibitory Peptide GpTx-1.
2016,
Pubmed
Nieto,
Tetrodotoxin (TTX) as a therapeutic agent for pain.
2012,
Pubmed
Osteen,
Selective spider toxins reveal a role for the Nav1.1 channel in mechanical pain.
2016,
Pubmed
Pan,
Molecular basis for pore blockade of human Na+ channel Nav1.2 by the μ-conotoxin KIIIA.
2019,
Pubmed
Peigneur,
Phoneutria nigriventer venom: A pharmacological treasure.
2018,
Pubmed
Peigneur,
Where cone snails and spiders meet: design of small cyclic sodium-channel inhibitors.
2019,
Pubmed
,
Xenbase
Peigneur,
δ-Conotoxins synthesized using an acid-cleavable solubility tag approach reveal key structural determinants for NaV subtype selectivity.
2014,
Pubmed
,
Xenbase
Peigneur,
Action of clathrodin and analogues on voltage-gated sodium channels.
2014,
Pubmed
,
Xenbase
Prashanth,
Pharmacology of predatory and defensive venom peptides in cone snails.
2017,
Pubmed
RANDALL,
A method for measurement of analgesic activity on inflamed tissue.
1957,
Pubmed
Richardson,
Comparison of the partial proteomes of the venoms of Brazilian spiders of the genus Phoneutria.
2006,
Pubmed
Robinson,
Venom peptides as therapeutics: advances, challenges and the future of venom-peptide discovery.
2017,
Pubmed
Silva,
Inhibitory effect of the recombinant Phoneutria nigriventer Tx1 toxin on voltage-gated sodium channels.
2012,
Pubmed
,
Xenbase
Stevens,
Design of bioactive peptides from naturally occurring μ-conotoxin structures.
2012,
Pubmed
,
Xenbase
Stevens,
Neurotoxins and their binding areas on voltage-gated sodium channels.
2011,
Pubmed
Van Der Haegen,
Importance of position 8 in μ-conotoxin KIIIA for voltage-gated sodium channel selectivity.
2011,
Pubmed
,
Xenbase
Vetter,
NaV1.7 as a pain target - From gene to pharmacology.
2017,
Pubmed
Wilson,
μ-Conotoxins that differentially block sodium channels NaV1.1 through 1.8 identify those responsible for action potentials in sciatic nerve.
2011,
Pubmed
,
Xenbase
Yu,
Determination of the α-conotoxin Vc1.1 binding site on the α9α10 nicotinic acetylcholine receptor.
2013,
Pubmed
Zhang,
Structure/function characterization of micro-conotoxin KIIIA, an analgesic, nearly irreversible blocker of mammalian neuronal sodium channels.
2007,
Pubmed
,
Xenbase
